To measure the clinical increase in alveolar ridge width after augmentation with self-prepared FDBA block graft and amnion chorion membrane
- Conditions
- Health Condition 1: K068- Other specified disorders of gingiva and edentulous alveolar ridge
- Registration Number
- CTRI/2024/01/061104
- Lead Sponsor
- Bhawana
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Subjects with ridge defect with ridge width(RW) less than 4mm which was insufficient for standard implant placement.
Presence of maxillary or mandibular single or multiple (maximum 3 teeth loss) horizontal ridge defects.
Absence of any sign of pathology at the proposed surgical sites.
Native Bone with any sign of pathology such as inflammation, or pus discharge.
Subjects with bone disease (Paget’s disease, rickets, osteoporosis, arthritis, multiple myeloma etc.) and Radiographic evidence of bone tumour (benign ormalignant) or any cyst.
Uncontrolled systemic diseases (uncontrolled diabetes, uncontrolled hypertension), taking immunosuppressive anticoagulant medications and pregnancy.
Subjects under longterm bisphosphonate therapy.
smokers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method •To evaluate the change in horizontal alveolar ridge width using FDBA block graft with Amnion-chorion membrane in deficient alveolar ridges. <br/ ><br>Timepoint: baseline and after 6 months
- Secondary Outcome Measures
Name Time Method To evaluate the clinical adverse effects of FDBA block graft and ACM, if any.Timepoint: baseline and after 6 months